Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
Anti-inflammatory treatments for gastrointestinal diseases can often have detrimental side effects. Here the authors engineer E. coli Nissle 1917 to create a fibrous matrix that has a protective effect in DSS-induced colitis mice.
Saved in:
Main Authors: | Pichet Praveschotinunt, Anna M. Duraj-Thatte, Ilia Gelfat, Franziska Bahl, David B. Chou, Neel S. Joshi |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/da22cd1382ed4f4c88ee9a65f788efef |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulating bacterial and gut mucosal interactions with engineered biofilm matrix proteins
by: Anna M. Duraj-Thatte, et al.
Published: (2018) -
Author Correction: Modulating bacterial and gut mucosal interactions with engineered biofilm matrix proteins
by: Anna M. Duraj-Thatte, et al.
Published: (2021) -
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
by: Sya N Ukena, et al.
Published: (2007) -
Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
by: Teresa Pérez-Berezo, et al.
Published: (2017) -
E. coli Nissle 1917 modulates host glucose metabolism without directly acting on glucose
by: Theodore A. Chavkin, et al.
Published: (2021)